Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK

Bansback N, Ward S, Karnon J

Eur J Health Econ. 2004 Jun;5(2):188-9

Leave a Comment

Previous post: Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK

Next post: Dad gets an OBE